| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |